Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 30, 2010
Risk and uncertainty in health investmentTakao Asano, Akihisa ShibataCardiovascular Psychiatry and Neurology|September 24, 2010
Targeting S100B in Cerebral Ischemia and in Alzheimer's DiseaseTakashi Mori, Takao Asano, Terrence TownNeurologia Medico-Chirurgica|March 21, 2002
Presigmoid transpetrosal approach for the treatment of a large trochlear nerve schwannoma--case reportToru Matsui, Eiharu Morikawa, Tadashi Morimoto, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 4, 2005
Modulation of astrocytic activation by arundic acid (ONO-2506) mitigates detrimental effects of the apolipoprotein E4 isoform after permanent focal ischemia in apolipoprotein E knock-in miceTakashi Mori, Terrence Town, Jun Tan, et al.Journal of Neuropathology and Experimental Neurology|March 18, 2003
Increased vulnerability to focal ischemic brain injury in human apolipoprotein E4 knock-in miceTakashi Mori, Mariko Kobayashi, Terrence Town, et al.Neurologia Medico-Chirurgica|June 18, 2002
Large giant cell reparative granuloma of the petrous bone--case reportToru Matsui, Kohichi Iwamuro, Tosiroh Ishikawa, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 8, 2004
Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in miceTakashi Mori, Terrence Town, Mariko Kobayashi, et al.Neurochemistry International|May 18, 2004
Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506Takashi Mori, Narito Tateishi, Yoshifumi Kagamiishi, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 5, 2002
Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficitsNarito Tateishi, Takashi Mori, Yoshifumi Kagamiishi, et al.The Journal of Pharmacology and Experimental Therapeutics|May 20, 2006
Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic miceTakashi Mori, Terrence Town, Jun Tan, et al.Pageof 2